期刊文献+

洛伐他汀原料药的萃取、纯化工艺研究 被引量:2

Study on Isolation and Purification Technology of Lovastatin
原文传递
导出
摘要 目的:建立洛伐他汀原料药的萃取、纯化工艺。方法:采用超临界CO2流体萃取,以萃取压力(A)、萃取温度(B)、夹带剂用量(C)、萃取时间(D)为考察因素,洛伐他汀萃取率为评价指标,设计L9(34)正交试验优化萃取工艺;采用超声洗涤法进行纯化,设计单因素试验考察洗涤溶剂、洗涤次数、洗涤剂用量对洛伐他汀纯度的影响,优化纯化工艺并进行验证试验。结果:优化萃取工艺为萃取压力25MPa、萃取温度55℃、夹带剂用量2.0mL·g-1、萃取时间100min;优化纯化工艺为95%乙醇为洗涤溶剂,洗涤4次,每次用量2mL·g-1,所得洛伐他汀纯度>98%。结论:该萃取、纯化工艺稳定、简便、可行。 OBJECTIVE:To establish the isolation and purification technology of lovastatin.METHODS:Supercritical CO2 fluid extraction was adopted.The extraction technology of lovastatin was optimized by L9(34) orthogonal design with extraction pressure(A),extraction temperature(B),the agent of entrainer(C) and extraction time(D) as factors and with the yield of the lovastatin as index.Ultrasonic elution was used for purification of samples.Single factor test was designed to investigate the effects of solvent,the washing times and amount of washing agent on the purity of lovastatin as factors to optimize the purification technology.Validation test was conducted.RESULTS:The optimum extraction conditions for lovastatin were as follows:the extraction pressure of 25 MPa,extraction temperature at 55 ℃,the agent of entrainer of 2.0 mL·g-1,extracting for 100 min.Purification condition was 95% ethanol as elution solution,washing for 4 times,2 mL·g-1 ethanol for each time.The purity of lovastatin achieved above 98%.CONCLUSION:This technology is stable,convenient and feasible.
出处 《中国药房》 CAS CSCD 2012年第9期816-818,共3页 China Pharmacy
基金 科技人员服务企业行动资助项目(2009GJF10023)
关键词 超临界CO2萃取 洛伐他汀 萃取工艺 纯化工艺 优化 纯度 Supercritical CO2 extraction Lovastatin Extraction technology Purification technology Optimization Purity
  • 相关文献

参考文献7

二级参考文献37

  • 1高蓝,李浩明.洛伐他汀生物合成及其相关基因研究进展[J].药物生物技术,2005,12(3):201-206. 被引量:11
  • 2孙永跃,李淑芬,宋慧婷,田松江.超临界CO_2萃取川芎中药效成分研究[J].化学工程,2006,34(3):60-63. 被引量:10
  • 3李菁,葛发欢,黄晓芬,李莹,辉国钧,吴惠勤.超临界CO_2萃取当归挥发油的研究[J].中药材,1996,19(4):187-189. 被引量:69
  • 4刘密新,汪伟.小茴香挥发油的成分分析[J].中草药,1997,28(1):14-14. 被引量:19
  • 5Suzanne M M, Yi Tang. Biochemical characterization of the minimal polyketide synthase domains in the lovastatin nonaketide synthase LovB [ J]. FEBS, 2007,274: 2854-2864.
  • 6Julia S, Christian H. Advances in cloning, functional analysis and heterologons expression of fungal polyketide synthase genes [ J]. Biotechnology, 2006 : 690-703.
  • 7Manzoni M, Rollini M. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs[ J]. APPI Microbiol Biotechnol,2002,58 : 555-564.
  • 8Andrey N G,Zophonias O J, Olafur S A, et al. Cloning and heterologous transcription of a polyketide synthase gene from the lichen Solorina crocea[ J]. Mycol Res, 2009,113 : 354-363.
  • 9Shen B. Polyketide biosynthesis beyond the type I , Ⅱ and Ⅲ polyketide synthase paradigms [ J ]. Curr Opin Chem Biol, 2003,7 ( 2 ) : 837- 849.
  • 10Jick H, Zomberg G L,Jick S S, et al. Statins and risk of dementia[J]. Lancet, 2000,356 : 1627-1631.

共引文献32

同被引文献21

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部